‘Empowering patients, policy makers, academics and the pharmaceutical industry to change the drug development process in order to speed up the delivery of life-saving and life-enhancing medicines to people with life-threatening and rare illnesses.’

By facilitating expert debate and discussion, online collaboration and sharing of best practice, the campaign aims to raise the issue of earlier access to medicine higher up both the political and media agenda.

Put patients at the heart of medical innovation

Patient organisations believe that their voice and engagement would make major, positive changes to priorities at several stages in the medical innovation process.

We are calling on the Government and political parties to unite behind a medical innovation manifesto for patients, to implement a programme that will see patients having a greater voice in their treatment, and to develop more adaptive pathways for clinical research and medical innovation.

Show your support on Change.org

Accelerating access for NHS patients to new medical innovations

George Freeman, life sciences minister, has pledged to create a “lit runway” for new drugs and devices from clinical trials through to adoption in the NHS that would “make Britain the best place in the world to get quicker access for patients to innovative medicines”.

Read more

The Four Campaign Pillars

  • A relaxation of regulations
  • Changes to the testing regime
  • A comprehensive review of treatments
  • A call for UK government to take an international lead

A relaxation of regulations

To allow patients with life-threatening illnesses to access drugs for their condition which have already been approved for other conditions.

The Campaign

Changes to the testing regime

To enable drugs to be developed more quickly for terminal illnesses

The Campaign

A comprehensive review of treatments

For all terminal, life-threatening and seriously life-encroaching conditions

The Campaign

A call for UK government to take an international lead

In encouraging medical research & development (R&D) to extend into minority conditions that are terminal, life-threatening and seriously life-encroaching

The Campaign